Live Quote · NASDAQEPRXHealthcare· Biotechnology

Eupraxia Pharmaceuticals Inc.

$5.80▼ 5.23%($-0.32)
MKT CAP $390.16MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
80
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPRX research report →

Analyst Price Target
$16.80+189.7% vs. today

Range $11 – $25

Analyst RatingBuy
2 Buy0 Hold0 Sell

Price Chart

-6.60% · this period
$9.10$7.45$5.80Nov 20May 26Nov 20
52-Week Range5% of range
Low
$5.63
Current
$5.80
High
$9.32